News

The deal, which is based on full R&D cost sharing, includes co-development, manufacturing and commercialization of the biosimilar compounds. Dr. Reddy’s will carry out early product development and

The generic version of Actelion’s Tracleer is indicated for pulmonary arterial hypertension. Mylan Canada president and CEO Dick Guest said, "By providing access to more affordable generic drugs,

The first notice of allowance is issued for patent application claiming BL-1021’s composition. Once issued, the patent will be valid until at least September 2022. The second one

The company manufactures a recombinant mammalian cell produced third-generation Sci-B-Vac in its biologics manufacturing facility in Rehovot, Israel. The multiple clinical studies conducted on Sci-B-Vac have demonstrated that

The marketing authorization follows the recently announced approval in Austria. The approvals were based on the completion of the decentralized regulatory procedure (DCP) in the European Union, in

The 24-week, double-blind, multinational, placebo-controlled, randomized study is designed to assess the safety and efficacy of Elagolix in 875 women, age 18 to 49, suffering with moderate-to-severe endometriosis-associated

The approval will expand Lupin’s range of Suprax dosage forms available to treat the approved indications in appropriate patients. At present Suprax is available as 100mg/5ml and 200mg/5ml

The generators allow Gallium-68 radionuclide production for use in Positron Emission Tomography. Eckert & Ziegler radiopharma segment head and board member Andre Heß said having enabled the availability

The companies are leveraging their strengths to deliver a range of solutions that have a direct impact on revenue cycle and clinical document initiatives. Dolbey vice-president Chris Casto